Tenet Healthcare price to free cash flow THC

Market value divided by free cash flow over the last twelve months, since 2011.

Today, Oct 23, 2026: 7.2×
10-year median: 7.4×
Against its 10-year history: 47th; percentile: 0 is its lowest day, 100 its highest
10-year range: 0.9× to 27.3×
Peer median: 22.6×

Tenet Healthcare's price to free cash flow is 7.2× as of Oct 23, 2026.

That is below its ten-year median of 7.4×, close to the middle of its last ten years.

Over that time it ranged from 0.9× in Oct 2020 to 27.3× in Feb 2023.

The median for 10 hospital and care facility stocks of a similar size is 22.6×.

Price to free cash flow over time

median 7.4×

The dashed line is the 10-year median and the shaded band the middle half of its days.

Open the interactive chart, with overlays and comparisons

Year by year

Year	End of year	Low	High
2026 so far	7.2×	4.2×	13.5×
2025	11.7×	4.9×	12.7×
2024	5.1×	5.1×	8.4×
2023	6.7×	4.8×	27.3×
2022	21.7×	6.8×	21.7×
2021	7.7×	1.7×	7.7×
2020	1.4×	0.9×	15.3×
2019	15.4×	2.8×	15.6×
2018	2.6×	2.6×	8.3×
2017	14.4×	10.8×	14.4×
2016	9.7×	5.6×	17.4×
2015	10.4×	9.5×	221×
2014	106×	99.7×	107×
2013	92.2×	14.7×	97.3×
2012	93.7×	93.7×	497×
2011	446×	362×	451×

Against its peers

Companies in Medical - Care Facilities nearest Tenet Healthcare's size, closest first, today.

Company	Price to free cash flow
THCTenet Healthcare	7.2×
EHCEncompass Health	29.6×
BTSGBrightSpring Health Services	29.6×
DVADavita	7.3×
UHSUniversal Health Services	13.0×
ENSGEnsign	24.4×
PACSPACS	16.6×
CHEChemed	20.7×
SHCSotera Health	45.8×
CONConcentra Group Holdings Parent	18.7×
LFSTLifeStance Health	28.4×
Peer median	22.6×

What the price to free cash flow tells you

Market value divided by free cash flow: the cash left after running the business and paying for equipment. Cash is harder to manage than accounting earnings, so many investors trust this more than PE.

Lumpy: a big year of building factories drops cash flow and inflates the ratio without the business getting worse.

More on Tenet Healthcare

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.